Mr. Zhang started his legal
profession in 2002 with Liu, Shen & Associates and he has been representing
domestic and international clients for many years. He focuses on all aspects of intellectual
property matters, ranging from patent application preparation and prosecution,
patent reexamination, patent invalidation and litigation, freedom-to-operate,
legal opinion, to due diligence, patent portfolio management, technology
transfers, licenses, and strategic alliances, copyrights, and trade secrets. In addition, Mr. Zhang also has a rich
experience in the protection of Plant New Varieties.
Mr. Zhang specializes in the
life science-related fields including biotechnology, immunology, vaccine, biochemistry,
molecular biology, pesticides, pharmaceutical, agriculture science, biomass,
biomaterial, botanical science & breeding, medical device, food &
nutrition science, feed science, environmental biology, cosmetic and detergent.
Prior to joining Liu Shen,
he was engaged in research and development in life science. In 2001, he worked at the Beijing Genomic
Institute, the Chinese Academy of Sciences and took part in the Rice Genome
Project, which was an international cooperation project launched by many
countries. In the late of 2007, he was
dispatched to a famous European company in life science field and sequentially worked
as consultant/patent attorney/patent manager in Patent & License department from 2007 to 2009.
EDUCATION &TRAINING
Mr. Zhang got his second
Master degree in Intellectual Property Law from the Law School of Peking
University in 2013. Before that, he
received a Bachelor of Science in Biology from Hebei University in 1998, and a
Master degree in Agricultural science from the graduate school of Chinese
Academy of Agricultural Science in 2001.
During the summer of 2007, he
visited Birch, Stewart, Kolasch & Birch, LLP at Washington DC, USA,
where he gained training in U.S. patent practice. In 2015, he was dispatched to a famous French
law firm in Paris and took part in the training in European patent practice.
Representative cases that Mr. Zhang has led or
participated include
- Bayer Pharma AG (German) v.
Novo Nordisk (Danmark) in the invalidation proceedings, representing Bayer and
winning this case;
- DSM IP Assets B.V. (Netherlands) v. Ni ShaoWei
(China)
in the invalidation proceedings, representing DSM and winning this case;
- Owen Mumford Limited (UK) v. Novo Nordisk (Danmark) in the
invalidation proceedings, representing Owen Mumford limited and winning this case;
- Bayer China limited v. Novo Nordisk (Danmark) in the
invalidation proceedings, representing Bayer and winning this case;
- Syngenta Participations(Switzerland) AG v. Shaanxi Meibang Pesticides Co.,
Ltd. in the invalidation proceedings, representing Syngenta;
- Syngenta Participations(Switzerland) AG v. Jiangsu Huifeng Agrochemical Co., Ltd.
- in the
invalidation proceedings, representing Syngenta;
- Academia
Sinica v. Tianjin Super
Biologic Technology Development Co. Ltd. in the invalidation
proceedings,
representing Academia Sinica and winning this case;
- BIOHEAP LIMITED (Australia) v. Patent Reexamination Board
of State Intellectual Property Office (China) in the litigation case,
representing BIOHEAP LIMITED;
- ORGANOGENESIS INC(US) v. Patent Reexamination Board of State
Intellectual Property Office (China) in the litigation case, representing
ORGANOGENESIS INC;
- DSM IP Assets B.V. (Netherlands) v. Ni ShaoWei
(China) in the litigation case, representing DSM.
Publications that Mr. Zhang has authored include
- Seven tips for technology transfer in China,
Managing Intellectual Property, July/August 2012;
- An Overview of Technology Transfer Including Patent
Licenses and Know-how Licenses in China, European Intellectual Property Review,
2013, Issue 3, Page 137-141;
- The Examination and
Protection of Claims Having Functional Definition: A Case of Bio-medical
Invention, Master’s Dissertation of Peking University, 2013.
- How to make sure your patent is properly supported
in China, Managing Intellectual Property, April 2016;
- Patent issues for life
science companies in China, Intellectual
Asset Management, life Sciences 2016;
- Inventorship Determination in China, 2016;
- Recent Advances in Protection of New Varieties of
Plants,2016;
- Guidance on determining who
is an inventor, Managing Intellectual Property, February 2017;
- Examination Practice of Antibody-related Patent Applications in China,
Lexology, November 2017;
- Brief introduction on cited documents, Patent Agency,
2018;